Sector News

Chemtrade to buy Canexus for $675 million

December 19, 2016
Energy & Chemical Value Chain

Chemtrade Logistics Income Fund (Toronto, Ontario, Canada) and Canexus (Calgary, Alberta, Canada) have reached an agreement, under which Chemtrade will acquire Canexus for C$1.65/share in cash.

The transaction is to be completed by way of a plan of arrangement under Alberta’s Business Corporations Act. The deal values Canexus at about C$900 million (US$675 million). The companies confirmed earlier this week that they were discussing a deal at C$1.65/share.

The acquisition price is a 33% premium to Canexus’s closing price of C$1.24/share on 13 September, the last trading day before Chemtrade announced its initial C$1.45/share bid for Canexus. That bid was rejected and Chemtrade launched a hostile C$1.50/share bid for Canexus in October. Chemtrade expects the deal to close by the end of April 2017, subject to regulatory approvals and customary closing conditions.

Shareholders accounting for about 20% of Canexus’s equity, including all Canexus directors and officers, and the company’s largest shareholder Stirling Global Value Fund, have entered into binding agreements to vote their shares in favor of the agreeement, Chemtrade says. Canexus’s shareholders will consider the agreement at a meeting to be held in early February 2017. The deal will require approval from at least 66.67% of shareholders at that meeting.

Chemtrade says it has sufficient capital to fund the acquisition from available cash resources and from firm, committed financing. The company is entitled to a termination fee of C$25 million if Canexus agrees to a “superior proposal” from another company, Chemtrade says. Chemtrade also has the right to match any unsolicited, superior proposal.

Canexus produces sodium chlorate and chlor-alkali products mainly for the pulp and paper, and water tratment industries. The company has production at four plants in Canada and two in Brazil. Chemtrade is a maker of inorganic chemicals, including sulfuric acid, coagulants for water treatment, and sodium chlorate. The proposed deal “will strengthen and expand Chemtrade’s existing platform while further diversifying our North American operations and allowing us to enter attractive South American markets,” says Chemtrade CEO Mark Davis.

Canexus says its board has “unanimously determined that the arrangement is in the best interests of Canexus.” CIBC Capital Markets and The Valence Group are advising Canexus.

By Ian Young

Source: Chemical Week

comments closed

Related News

April 20, 2024

Borealis makes multi-million investment in Finnish cracker furnaces

Energy & Chemical Value Chain

The investment enables the steam cracker to increase the share of renewable and recycled raw materials used in its (ethylene and propylene) production. The move supports the Borealis Strategy 2030 for a circular economy. The Porvoo investment program is expected to be completed in 2025.

April 20, 2024

BP cuts down leadership team to ten members

Energy & Chemical Value Chain

Murray Auchincloss, bp’s CEO, said in a statement: “As I set out in February, BP’s destination from IOC [international oil company] to IEC [integrated energy company] is unchanged – and we need to deliver as a simpler, more focused, and higher-value company.

April 20, 2024

Versalis buys Italian compounder Tecnofilm

Energy & Chemical Value Chain

Founded in 1972, Tecnofilm has expanded its product portfolio over the years to offer a wider range of compounds and functional polymers for various industrial applications and technical articles. The company has patented several of its products.

How can we help you?

We're easy to reach